Skip to main contentSkip to footer

STERIS acquires harwell dosimeters limited

August 28, 2017

STERIS is pleased to announce the acquisition of Harwell Dosimeters Limited, which will become a part of our STERIS Applied Sterilization Technologies (AST) business.

Founded in 1960, Harwell is based in Didcot, Oxfordshire, United Kingdom and is recognized for quality products and its Customer service capabilities. The company manufactures both red Perspex and alanine pellet dosimeters used to measure ionizing radiation.

The addition of Harwell Dosimeters to the STERIS AST offering further supports our commitment to providing Customers with comprehensive contract sterilization and laboratory testing services worldwide.

harwell-dosimeters-logo

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 

WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe.

For more information, visit www.steris.com.

 
Related Posts
STERIS Venlo, NL Facility
October 8, 2026
As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completion of the expansion of its existing Venlo, The Netherlands ethylene oxide and X-ray processing facility to include a second X-ray processing line. 
STERIS Alajuela, Costa Rica
September 29, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the expansion of the laboratory testing capabilities available at our facility in Alajuela, Costa Rica.

STERIS Ede, The Netherlands Laboratory
September 28, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce that the Ede, The Netherlands laboratory has achieved ISO 17025 accreditation.

Montreal Opening Announcement
August 24, 2026

As part of our commitment to ensuring patient and consumer safety, STERIS is pleased to announce the competition of a new electron beam (E-beam) processing facility in Montreal, Canada.